Cardiovascular risk during physical activity in the mountains

Journal of Cardiovascular Medicine
Andrea PonchiaSergio Dalla Volta

Abstract

Several previous studies evaluated the cardiovascular risk associated with exercise, but only a few papers considered this risk during physical activity in the mountains. The aim of this study was to assess the cardiovascular risk in a population practising physical activity in the mountains. We used an observational study design. We estimated the population by integrating the data of presences in the accommodation establishments with data from telephone and on-field interviews. As survey sources of cardiovascular events we used the reports of the Mountain Rescue teams and of the emergency physicians and pathologists operating in the hospitals of the considered mountain area. We estimated that the duration of exposure to risk for the study population was, averagely per year, 12 449 877 person-days. During the study period, we recorded 117 cardiovascular events, namely 38 sudden cardiac deaths, 13 acute coronary syndromes, and five strokes. The remaining 61 events were non-traumatic events with a probable cardiovascular origin. We calculated one cardiovascular event per 319 000 person-days of physical activity in the mountains, one sudden cardiac death per 980 000 and one acute coronary syndrome per 2 895 000 person-days. The ri...Continue Reading

References

Jun 1, 1977·International Journal of Biometeorology·I SinghM S Malhotra
Jan 1, 1978·Cardiology·I VuoriA Jäskeläinen
Jan 1, 1978·Advances in Cardiology·R KalaP I Halonen
Jan 11, 1992·Epidemiologic Reviews·H W KohlR S Paffenbarger
Jun 1, 1990·Archives of Internal Medicine·R F GroverR R Travis
Sep 1, 1987·Annals of Emergency Medicine·L G Moore
Oct 4, 1984·The New England Journal of Medicine·D S SiscovickT Lasky
May 14, 1982·JAMA : the Journal of the American Medical Association·P D ThompsonW Q Sturner
Oct 17, 1980·JAMA : the Journal of the American Medical Association·L W GibbonsR C Ellison
May 1, 1995·Medicine and Science in Sports and Exercise·S P Van CampH G Olson
Dec 2, 1993·The New England Journal of Medicine·M BurtscherR Likar
Jul 1, 1993·The New England Journal of Medicine·B J Maron
Aug 1, 1996·Journal of the American College of Cardiology·B J MaronW O Roberts
Aug 6, 1998·The New England Journal of Medicine·D CorradoG Thiene
Dec 19, 1998·Journal of the American College of Cardiology·B J MaronD Aeppli
Nov 9, 2000·The New England Journal of Medicine·C M AlbertJ E Manson
Sep 12, 2003·The New England Journal of Medicine·Barry J Maron
Jun 1, 1982·The Physician and Sportsmedicine·Lauren VanderMelvyn Rubenfire

❮ Previous
Next ❯

Citations

Aug 2, 2011·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Jack M GoodmanJamie Burr
Sep 22, 2012·High Altitude Medicine & Biology·Peter PaalJohn Ellerton
Feb 26, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·U KappertK Matschke
Mar 29, 2016·The Canadian Journal of Cardiology·Jack M GoodmanScott G Thomas
Apr 27, 2010·Progress in Cardiovascular Diseases·Martin Burtscher, Andrea Ponchia
Jan 16, 2010·Journal of Travel Medicine·Kelly MieskeTimothy O'Brien
Mar 13, 2009·High Altitude Medicine & Biology·Shih-Hao WangHang-Cheng Chen
Sep 20, 2008·High Altitude Medicine & Biology·Giacomo StrapazzonAndrea Semplicini
Dec 14, 2011·Journal of Strength and Conditioning Research·Luigi FattoriniAngelo Rodio
Feb 27, 2020·Circulation·Barry A FranklinUNKNOWN American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Ca
Mar 24, 2020·Forensic Science International : Synergy·Severin ZürcherCorinna A Schön

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.